Skip to main content
Top
Published in: Annals of Surgical Oncology 12/2017

01-11-2017 | Endocrine Tumors

The Impact of Nodal Dissection on Staging in Adrenocortical Carcinoma

Authors: Suraj Panjwani, MBBS, Maureen D. Moore, MD, Katherine D. Gray, MD, Brendan M. Finnerty, MD, Toni Beninato, MD, Laurent Brunaud, MD, Thomas J. Fahey III, MD, Rasa Zarnegar, MD

Published in: Annals of Surgical Oncology | Issue 12/2017

Login to get access

Abstract

Background

The role of lymphadenectomy in adrenocortical carcinoma (ACC) is controversial, and formal lymph node (LN) dissection is not routine. We sought to determine the minimum number of LNs that must be examined to accurately identify a patient as node negative.

Methods

The National Cancer Database was used to identify patients diagnosed with ACC from 2004 to 2013 who underwent surgical resection. Patients with distant metastases, multivisceral resection, or missing surgical or lymphadenectomy data were excluded. The primary outcome was overall survival (OS).

Results

LNs were identified on histopathology in 156 patients. Of these, 35 (22%) had at least one positive LN. Positive LNs were associated with positive surgical margins (odds ratio [OR] 5.80, p = 0.002) and increasing LN yield (OR 1.06, p = 0.02). Overall, on Cox regression analysis, LN positivity (hazard ratio [HR] 3.02, p < 0.001) and positive surgical margins (HR 2.06, p = 0.048) independently predicted poor OS after controlling for other factors that may influence survival. LN(−) disease in patients with one to three LNs examined had poorer overall survival compared with when at least four LNs were examined (p = 0.02). None of the other patient, tumor, and treatment variables had any impact on OS of the LN(−) cohort. The likelihood of identifying nodal involvement was higher on examination of at least four LNs compared with examination of one to three LNs (30 vs. 16%, p = 0.03).

Conclusions

LN positivity in ACC tumors independently predicts worse 5-year OS and a minimum of four LNs may be required to accurately determine LN negativity.
Appendix
Available only for authorised users
Literature
3.
go back to reference Kerkhofs TMA, Verhoeven RHA, Bonjer HJ, et al. Surgery for adrenocortical carcinoma in The Netherlands: analysis of the national cancer registry data. Eur J Endocrinol. 2013;169(1):83–89. doi:10.1530/EJE-13-0142.CrossRefPubMed Kerkhofs TMA, Verhoeven RHA, Bonjer HJ, et al. Surgery for adrenocortical carcinoma in The Netherlands: analysis of the national cancer registry data. Eur J Endocrinol. 2013;169(1):83–89. doi:10.​1530/​EJE-13-0142.CrossRefPubMed
4.
go back to reference Lughezzani G, Sun M, Perrotte P, et al. The European Network for the Study of Adrenal Tumors staging system is prognostically superior to the international union against cancer-staging system: a North American validation. Eur J Cancer. 2010;46(4):713–19. doi:10.1016/j.ejca.2009.12.007.CrossRefPubMed Lughezzani G, Sun M, Perrotte P, et al. The European Network for the Study of Adrenal Tumors staging system is prognostically superior to the international union against cancer-staging system: a North American validation. Eur J Cancer. 2010;46(4):713–19. doi:10.​1016/​j.​ejca.​2009.​12.​007.CrossRefPubMed
5.
go back to reference Fassnacht M, Johanssen S, Quinkler M, et al. Limited prognostic value of the 2004 International Union Against Cancer staging classification for adrenocortical carcinoma: proposal for a Revised TNM Classification. Cancer. 2009;115(2):243–50. doi:10.1002/cncr.24030.CrossRefPubMed Fassnacht M, Johanssen S, Quinkler M, et al. Limited prognostic value of the 2004 International Union Against Cancer staging classification for adrenocortical carcinoma: proposal for a Revised TNM Classification. Cancer. 2009;115(2):243–50. doi:10.​1002/​cncr.​24030.CrossRefPubMed
17.
go back to reference Pommier RF, Brennan MF. An 11-year experience with adrenocortical carcinoma. Surgery. 1992;112(6):963–70; discussion 970.PubMed Pommier RF, Brennan MF. An 11-year experience with adrenocortical carcinoma. Surgery. 1992;112(6):963–70; discussion 970.PubMed
22.
go back to reference Maurel J, Launoy G, Grosclaude P, et al. Lymph node harvest reporting in patients with carcinoma of the large bowel: a French population-based study. Cancer. 1998;82(8):1482–86.CrossRefPubMed Maurel J, Launoy G, Grosclaude P, et al. Lymph node harvest reporting in patients with carcinoma of the large bowel: a French population-based study. Cancer. 1998;82(8):1482–86.CrossRefPubMed
23.
25.
Metadata
Title
The Impact of Nodal Dissection on Staging in Adrenocortical Carcinoma
Authors
Suraj Panjwani, MBBS
Maureen D. Moore, MD
Katherine D. Gray, MD
Brendan M. Finnerty, MD
Toni Beninato, MD
Laurent Brunaud, MD
Thomas J. Fahey III, MD
Rasa Zarnegar, MD
Publication date
01-11-2017
Publisher
Springer International Publishing
Published in
Annals of Surgical Oncology / Issue 12/2017
Print ISSN: 1068-9265
Electronic ISSN: 1534-4681
DOI
https://doi.org/10.1245/s10434-017-6064-3

Other articles of this Issue 12/2017

Annals of Surgical Oncology 12/2017 Go to the issue